FaultyDrugs.com

Statin drugs and risk of amyotrophic lateral sclerosis

Statin drugs and amyotrophic lateral sclerosis (ALS) Audience: Neurologists, cardiologists, consumers An FDA analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as “Lou Gehrig’s Disease.” The FDA analysis, undertaken after the agency received a higher than expected number of reports of [...]

Continue reading...